If you are not happy with the results below please do another search
Irish medical device company Perfuze has achieved two significant milestones in advancing acute ischemic stroke treatment technology. The firm has received FDA 510(k) clearance for its Zipline™ Access Catheters alongside securing €22 million in follow-on funding to support commercial rollout and ongoing research initiatives.
Olympus Corporation of Asia Pacific Limited has announced expanded availability of its iTind™ device across major Asia-Pacific markets. This minimally invasive treatment for benign prostatic hyperplasia (BPH) will soon launch in Korea, making it available in six APAC markets, supporting Olympus’s commitment to improving urological health outcomes.
LivsMed has developed the world’s first 90° double-jointed articulating vessel sealer, set to transform minimally invasive surgical procedures. The ArtiSeal™ Vessel Sealing System enables perpendicular tissue sealing with potential benefits for seal integrity and surgical precision in challenging anatomical locations.
JUNE Medical is introducing a novel 3-in-1 hand surgery solution that eliminates the need for surgical assistants while enhancing surgical access and visibility. The HandMe Galaxy II Retractor, designed for complex procedures including Dupuytren’s contracture, features unique finger securing mechanisms and precision retraction hooks that simplify hand surgery workflow.
BIOHIT OYJ has launched the FAEX™ Sample System, a CE-marked stool collection and handling solution designed for seamless integration into diagnostic workflows. This multi-functional system combines standardised collection with precision dispensing capabilities to address laboratory efficiency needs while improving patient compliance in gastroenterological specimen collection.
Symphony Robotics has obtained exclusive rights to an MRI-guided flexible micro-robotic arm technology from Case Western Reserve University, aimed at revolutionising brain tumour treatment, particularly for Glioblastoma Multiforme (GBM), through minimally invasive precision surgery.
Seal Shield has unveiled custom-fitted Clean Seal™ Privacy Screen Protectors designed for healthcare environments, offering enhanced visual privacy protection while maintaining compliance with HIPAA regulations for secure patient data management.
Oneview Healthcare has developed a GenAI-powered care assistant called Ovie that aims to provide 24/7 support for patients while alleviating nursing burden. The voice-activated system integrates with hospital electronic health records to deliver personalised responses to patient queries and requests.
GeneDx has introduced ultraRapid Whole Genome Sequencing technology that delivers diagnostic results for critically ill neonatal and paediatric patients in as little as 48 hours, potentially saving healthcare systems over $15,000 per child while significantly improving clinical outcomes.
Cambridge-based scientists have developed a novel diagnostic approach for prostate cancer detection, utilising advanced biomarker analysis and AI interpretation. The test, developed by EDX Medical Group, aims to transform screening accuracy by simultaneously evaluating over 100 clinically validated biomarkers in both blood and urine samples.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
